Back to top
more

OBALON THERPTCS (OBLN)

(Delayed Data from NSDQ)

$0.43 USD

0.43
220,855

-0.01 (-3.15%)

Updated May 3, 2019 03:59 PM ET

After-Market: $0.43 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

0 items in cart

ReShape Lifesciences Inc. [OBLN]

Reports for Purchase

Showing records 1 - 20 ( 27 total )

Company: ReShape Lifesciences Inc.

Industry: Medical - Instruments

Record: 1

10/08/2019

Company Report

Pages: 10

ValuEngine Detailed Valuation Report for OBLN

Provider: ValuEngine, Inc

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: ReShape Lifesciences Inc.

Industry: Medical - Instruments

Record: 2

07/24/2019

Company Report

Pages: 4

Dropping Coverage

Provider: Roth Capital Partners, Inc.

Analyst: HENRY S

Price: 10.00

Research Provided by a Third Party

Company: ReShape Lifesciences Inc.

Industry: Medical - Instruments

Record: 3

04/08/2019

Daily Note

Pages: 3

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: ReShape Lifesciences Inc.

Industry: Medical - Instruments

Record: 4

04/08/2019

Company Report

Pages: 6

Updated Model Post Salesforce Dismissal

Provider: Roth Capital Partners, Inc.

Analyst: HENRY S

Price: 25.00

Research Provided by a Third Party

Company: ReShape Lifesciences Inc.

Industry: Medical - Instruments

Record: 5

02/26/2019

Daily Note

Pages: 4

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: ReShape Lifesciences Inc.

Industry: Medical - Instruments

Record: 6

02/25/2019

Company Report

Pages: 6

4Q18 Recap - Neutral Pending Signs of Significant Traction

Provider: Roth Capital Partners, Inc.

Analyst: HENRY S

Price: 25.00

Research Provided by a Third Party

Company: ReShape Lifesciences Inc.

Industry: Medical - Instruments

Record: 7

02/05/2019

Company Report

Pages: 4

We are transferring lead coverage to Scott Henry due to the departure of the covering analyst

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: ReShape Lifesciences Inc.

Industry: Medical - Instruments

Record: 8

02/05/2019

Daily Note

Pages: 3

We are transferring coverage, placing Under Review, and removing PT''s and estimates

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: ReShape Lifesciences Inc.

Industry: Medical - Instruments

Record: 9

01/03/2019

Daily Note

Pages: 4

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: ReShape Lifesciences Inc.

Industry: Medical - Instruments

Record: 10

01/02/2019

Company Report

Pages: 4

Planned Leadership Transition Complete

Provider: Roth Capital Partners, Inc.

Analyst: SOLOMON D

Price: 10.00

Research Provided by a Third Party

Company: ReShape Lifesciences Inc.

Industry: Medical - Instruments

Record: 11

12/24/2018

Daily Note

Pages: 3

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: ReShape Lifesciences Inc.

Industry: Medical - Instruments

Record: 12

12/21/2018

Daily Note

Pages: 4

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: ReShape Lifesciences Inc.

Industry: Medical - Instruments

Record: 13

12/21/2018

Daily Note

Pages: 5

Christmas Comes Early

Provider: Roth Capital Partners, Inc.

Analyst: SOLOMON D

Price: 10.00

Research Provided by a Third Party

Company: ReShape Lifesciences Inc.

Industry: Medical - Instruments

Record: 14

12/20/2018

Daily Note

Pages: 4

Swap Appears Positive For OBLN

Provider: Roth Capital Partners, Inc.

Analyst: SOLOMON D

Price: 10.00

Research Provided by a Third Party

Company: ReShape Lifesciences Inc.

Industry: Medical - Instruments

Record: 15

11/26/2018

Industry Report

Pages: 5

Healthcare - Medical Technology: Key Takeaways From Obesity Week on U.S. Balloon Market

Provider: Roth Capital Partners, Inc.

Analyst: SOLOMON D

Price: 10.00

Research Provided by a Third Party

Company: ReShape Lifesciences Inc.

Industry: Medical - Instruments

Record: 16

11/15/2018

Daily Note

Pages: 3

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: ReShape Lifesciences Inc.

Industry: Medical - Instruments

Record: 17

11/15/2018

Daily Note

Pages: 5

Clinical Data Validates Obalon''s Safety, Tolerability - Efficacy

Provider: Roth Capital Partners, Inc.

Analyst: SOLOMON D

Price: 10.00

Research Provided by a Third Party

Company: ReShape Lifesciences Inc.

Industry: Medical - Instruments

Record: 18

11/05/2018

Daily Note

Pages: 4

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: ReShape Lifesciences Inc.

Industry: Medical - Instruments

Record: 19

11/05/2018

Company Report

Pages: 7

3Q18 Beat, Sights Set on ASMBS Data

Provider: Roth Capital Partners, Inc.

Analyst: SOLOMON D

Price: 25.00

Research Provided by a Third Party

Company: ReShape Lifesciences Inc.

Industry: Medical - Instruments

Record: 20

09/27/2018

Daily Note

Pages: 4

Touch PMA-S Approved, Sights Set on ASMBS Data and Navigation Decision

Provider: Roth Capital Partners, Inc.

Analyst: SOLOMON D

Price: 10.00

Research Provided by a Third Party